Morgan Stanley Maintains an Overweight Rating on Generate Biomedicines, Inc. (GENB)

24 6 月, 2026

One Min Read

1 Views

原文: https://finance.yahoo.com/healthcare/articles/morgan-stanley-maintains-overweight-rating-193922956.html

Last Update: 24 6 月, 2026

Written By

Other Articles

Previous

SpaceX Is Eyeing a $20 Billion Bond Sale After Its Historic IPO. What That Means for SPCX Stock Investors.

Next

Jazz Pharmaceuticals and AbCellera Biologics Inc. (ABCL) Announce Collaboration

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept